Enhancing the QUAlity and Transparency Of health Research
Use your browser's Back button to return to your search results
Reporting guideline provided for? (i.e. exactly what the authors state in the paper) |
Reporting intervention description across studies assessing the impact of clinical pharmacy activities. |
Full bibliographic reference | Rotta I, Salgado TM, Felix DC, Souza TT, Correr CJ, Fernandez-Llimos F. Ensuring consistent reporting of clinical pharmacy services to enhance reproducibility in practice: an improved version of DEPICT. J Eval Clin Pract. 2015;21(4):584-590. |
Language | English |
PubMed ID | 25676042 |
Reporting guideline acronym | DEPICT 2 |
Study design | Clinical trials, Experimental studies |
Clinical area | Pharmaceutical medicine |
Applies to the whole report or to individual sections of the report? | Intervention (exposure) |
Previous versions of this guideline / Guideline history | An earlier version of this reporting guideline was published in 2013: Correr CJ, Melchiors AC, de Souza TT, Rotta I, Salgado TM, Fernandez-Llimos F. A tool to characterize the components of pharmacist interventions in clinical pharmacy services: the DEPICT project. Ann Pharmacother. 2013;47(7-8):946-952. PMID: 23757389 |
Record last updated on | November 26, 2021 |